295 related articles for article (PubMed ID: 22495546)
1. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.
Kuo SC; Lee YT; Yang SP; Chiang MC; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):634-9. PubMed ID: 22776466
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
4. Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia.
Kang FY; How CK; Wang YC; Cheng A; Yang YS; Kuo SC; Liu CP; Liu YM; Chen TL; Lee YT
Antimicrob Resist Infect Control; 2020 Sep; 9(1):160. PubMed ID: 32993810
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Anunnatsiri S; Tonsawan P
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
[TBL] [Abstract][Full Text] [Related]
7. Mortality risk factors of Acinetobacter baumannii bacteraemia.
Choi JY; Park YS; Kim CO; Park YS; Yoon HJ; Shin SY; Kim YA; Song YG; Yong D; Lee K; Kim JM
Intern Med J; 2005 Oct; 35(10):599-603. PubMed ID: 16207259
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial Acinetobacter nosocomialis bacteremia.
Lai HH; Liou BH; Chang YY; Kuo SC; Lee YT; Chen TL; Fung CP
J Microbiol Immunol Infect; 2016 Jun; 49(3):371-7. PubMed ID: 25081987
[TBL] [Abstract][Full Text] [Related]
9. Predictors of mortality in surgical patients with Acinetobacter baumannii bacteremia.
Chen SJ; Chao TF; Chiang MC; Kuo SC; Chen LY; Chiang DH; Yin T; Chen TL; Fung CP
J Microbiol Immunol Infect; 2011 Jun; 44(3):209-14. PubMed ID: 21524616
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.
Falagas ME; Kasiakou SK; Rafailidis PI; Zouglakis G; Morfou P
J Antimicrob Chemother; 2006 Jun; 57(6):1251-4. PubMed ID: 16627593
[TBL] [Abstract][Full Text] [Related]
11. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
Lee YT; Kuo SC; Yang SP; Lin YT; Chiang DH; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):640-5. PubMed ID: 22967204
[TBL] [Abstract][Full Text] [Related]
12. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality.
Mylotte JM; Kahler L; McCann C
Am J Infect Control; 2001 Feb; 29(1):13-9. PubMed ID: 11172313
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia.
Lee NY; Chang TC; Wu CJ; Chang CM; Lee HC; Chen PL; Lee CC; Ko NY; Ko WC
J Infect; 2010 Sep; 61(3):219-27. PubMed ID: 20624424
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study.
Shih MJ; Lee NY; Lee HC; Chang CM; Wu CJ; Chen PL; Ko NY; Ko WC
J Microbiol Immunol Infect; 2008 Apr; 41(2):118-23. PubMed ID: 18473098
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of risk factors on prognosis of Acinetobacter baumannii bloodstream infection].
Qiao L; Zhang JS; Mei YN; Zhang HZ; Su CL
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):471-4. PubMed ID: 24021042
[TBL] [Abstract][Full Text] [Related]
17. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.
Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M
J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification.
Chiang DH; Wang CC; Kuo HY; Chen HP; Chen TL; Wang FD; Cho WL; Liu CY
J Microbiol Immunol Infect; 2008 Oct; 41(5):397-402. PubMed ID: 19122921
[TBL] [Abstract][Full Text] [Related]
19. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes.
Lee YC; Huang YT; Tan CK; Kuo YW; Liao CH; Lee PI; Hsueh PR
J Antimicrob Chemother; 2011 Aug; 66(8):1839-46. PubMed ID: 21653602
[TBL] [Abstract][Full Text] [Related]
20. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia.
Chuang YC; Sheng WH; Li SY; Lin YC; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2011 Feb; 52(3):352-60. PubMed ID: 21193494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
